Samreen Ahmed

3.5k total citations
59 papers, 1.0k citations indexed

About

Samreen Ahmed is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Samreen Ahmed has authored 59 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Samreen Ahmed's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (8 papers) and Cancer Treatment and Pharmacology (7 papers). Samreen Ahmed is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (8 papers) and Cancer Treatment and Pharmacology (7 papers). Samreen Ahmed collaborates with scholars based in United Kingdom, United States and Switzerland. Samreen Ahmed's co-authors include Fehmidah Munir, Penella J. Woll, Deborah J. Wallis, Judy M. Coulson, Kajal Gokal, Kiran Kancherla, James Thompson, Bryan J. Thibodeau, Ion Boiangiu and George D. Wilson and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Samreen Ahmed

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samreen Ahmed United Kingdom 18 374 333 294 136 117 59 1.0k
Christian Cadeddu Dessalvi Italy 27 477 1.3× 347 1.0× 278 0.9× 70 0.5× 149 1.3× 106 2.1k
Aarti Asnani United States 21 393 1.1× 488 1.5× 213 0.7× 107 0.8× 78 0.7× 59 1.4k
O. Christensen Germany 15 484 1.3× 368 1.1× 286 1.0× 104 0.8× 82 0.7× 30 1.1k
Yun Jung Choi South Korea 16 452 1.2× 499 1.5× 378 1.3× 183 1.3× 51 0.4× 59 1.2k
Abolhasan Rezaeyan Iran 19 198 0.5× 410 1.2× 269 0.9× 92 0.7× 124 1.1× 28 1.3k
Paiboon Jungsuwadee United States 17 233 0.6× 306 0.9× 286 1.0× 48 0.4× 112 1.0× 25 1.0k
Yi Zhao China 19 304 0.8× 311 0.9× 159 0.5× 190 1.4× 51 0.4× 71 1.1k
Yanping Sun China 21 476 1.3× 824 2.5× 401 1.4× 235 1.7× 180 1.5× 45 1.8k
Karen J. Klamerus United States 17 347 0.9× 500 1.5× 382 1.3× 142 1.0× 36 0.3× 41 1.3k

Countries citing papers authored by Samreen Ahmed

Since Specialization
Citations

This map shows the geographic impact of Samreen Ahmed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samreen Ahmed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samreen Ahmed more than expected).

Fields of papers citing papers by Samreen Ahmed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samreen Ahmed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samreen Ahmed. The network helps show where Samreen Ahmed may publish in the future.

Co-authorship network of co-authors of Samreen Ahmed

This figure shows the co-authorship network connecting the top 25 collaborators of Samreen Ahmed. A scholar is included among the top collaborators of Samreen Ahmed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samreen Ahmed. Samreen Ahmed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herbst, Roy S., Byoung Chul Cho, Mauricio Burotto, et al.. (2025). Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 LEAP-006 Study. Journal of Thoracic Oncology. 20(9). 1302–1314.
2.
Ahmed, Samreen, et al.. (2024). Principles of systemic anticancer therapy (SACT). Surgery (Oxford). 42(3). 164–169. 1 indexed citations
3.
Kristeleit, Hartmut, Vivek Misra, Mark Baxter, et al.. (2022). Eribulin Treatment for Patients with Metastatic Breast Cancer: The UK Experience – A Multicenter Retrospective Study. Oncology. 100(12). 666–673. 2 indexed citations
4.
Wilson, Thomas E., Samreen Ahmed, Jake Higgins, Jesse J. Salk, & Thomas W. Glover. (2022). svCapture: efficient and specific detection of very low frequency structural variant junctions by error-minimized capture sequencing. NAR Genomics and Bioinformatics. 5(2). lqad042–lqad042. 2 indexed citations
6.
Gokal, Kajal, Fehmidah Munir, Samreen Ahmed, Kiran Kancherla, & Deborah J. Wallis. (2018). Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial. PLoS ONE. 13(11). e0206874–e0206874. 45 indexed citations
7.
Woll, Penella J., Piers Gaunt, Nicola Steele, et al.. (2017). P1.07-015 STOMP: A UK National Cancer Research Network Randomised, Double Blind, Multicentre Phase II Trial of Olaparib as Maintenance Therapy in SCLC. Journal of Thoracic Oncology. 12(1). S704–S705. 17 indexed citations
8.
9.
Tonlaar, Nathan, Sandra Galoforo, Bryan J. Thibodeau, et al.. (2017). Antitumor activity of the dual PI3K/MTOR inhibitor, PF-04691502, in combination with radiation in head and neck cancer. Radiotherapy and Oncology. 124(3). 504–512. 19 indexed citations
10.
Geddes, Timothy J., et al.. (2015). Utilizing In-House Resources to Correct Sample Mixups in a Medium Throughput Biorepository: A Case Study. Biopreservation and Biobanking. 14(1). 75–80. 4 indexed citations
11.
Gokal, Kajal, Deborah J. Wallis, Samreen Ahmed, et al.. (2015). Effects of a self-managed home-based walking intervention on psychosocial health outcomes for breast cancer patients receiving chemotherapy: a randomised controlled trial. Supportive Care in Cancer. 24(3). 1139–1166. 84 indexed citations
12.
Geddes, Timothy J., Samreen Ahmed, Barbara L. Pruetz, et al.. (2013). SPIN: Development of Sample-specific Protein Integrity Numbers as an Index of Biospecimen Quality. Biopreservation and Biobanking. 11(1). 25–32. 6 indexed citations
13.
Thibodeau, Bryan J., Timothy J. Geddes, Samreen Ahmed, et al.. (2012). Gene Expression Changes Associated With the Progression of Intraductal Papillary Mucinous Neoplasms. Pancreas. 41(4). 611–618. 11 indexed citations
14.
Ahmed, Samreen, He Meng, Tiecheng Liu, et al.. (2011). Ischemic stroke selectively inhibits REM sleep of rats. Experimental Neurology. 232(2). 168–175. 14 indexed citations
15.
Munir, Fehmidah, et al.. (2011). Cognitive Intervention for Breast Cancer Patients Undergoing Adjuvant Chemotherapy. Cancer Nursing. 34(5). 385–392. 49 indexed citations
16.
Scott, Edwina N., Anne Thomas, L Rhoda Molife, et al.. (2009). A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumours. Cancer Chemotherapy and Pharmacology. 64(2). 425–429. 32 indexed citations
17.
Huang, Zheping, Tiecheng Liu, Asamanja Chattoraj, et al.. (2008). Posttranslational regulation of TPH1 is responsible for the nightly surge of 5‐HT output in the rat pineal gland. Journal of Pineal Research. 45(4). 506–514. 39 indexed citations
18.
Ahmed, Samreen, Jie Deng, & Jimo Borjigin. (2005). A new strain of rat for functional analysis of PINA. Molecular Brain Research. 137(1-2). 63–69. 25 indexed citations
19.
Ahmed, Samreen, Anne Thomas, & W P Steward. (2004). Vascular Endothelial Growth Factor (VEGF) Inhibition by Small Molecules. Journal of Chemotherapy. 16(sup4). 59–63. 32 indexed citations
20.
Coulson, Judy M., Samreen Ahmed, John P. Quinn, & Penella J. Woll. (2003). Detection of Small Cell Lung Cancer by RT-PCR for Neuropeptides, Neuropeptide Receptors, or a Splice Variant of the Neuron Restrictive Silencer Factor. Lung Cancer. 75. 335–352. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026